Hikma Pharmaceuticals PLC
(FRA:H5P)
€
22.2
0.2 (0.91%)
Market Cap: 4.91 Bil
Enterprise Value: 5.81 Bil
PE Ratio: 27.25
PB Ratio: 2.33
GF Score: 89/100 Half Year 2024 Hikma Pharmaceuticals PLC Earnings Presentation (Pre-Recorded) Transcript
Aug 08, 2024 / 06:00AM GMT
Release Date Price:
€22.6
(+5.61%)
Riad Mishlawi
Hikma Pharmaceuticals PLC - Chief Executive Officer, Executive Director
Presentation (Pre-Recorded)
Aug 08, 2024 / 06:00AM GMT
=====================
Corporate Participants
=====================
* Riad Mishlawi
Hikma Pharmaceuticals PLC - Chief Executive Officer, Executive Director
* Khalid Nabilsi
Hikma Pharmaceuticals PLC - Chief Financial Officer
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot